High Tech Pharm Co., Ltd. (KOSDAQ:106190)

High Tech Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13,638	7,759	3,483	7,880	11,275	1,038
Trading Asset Securities	1,066	-	1,882	-	1,363	-
Cash & Short-Term Investments	14,704	7,759	5,365	7,880	12,637	1,038
Cash Growth	95.06%	44.63%	-31.92%	-37.64%	1117.51%	-89.95%
Accounts Receivable	20,722	20,330	24,443	28,476	9,413	19,564
Other Receivables	18.01	27.43	40.1	78.47	58.39	112.9
Receivables	20,740	20,357	24,483	28,555	9,472	19,677
Inventory	31,814	34,813	25,498	14,676	17,708	18,632
Prepaid Expenses	1,198	1,304	1,191	885.83	545.12	1,078
Other Current Assets	13.93	1.13	33.78	43.53	126.73	51.48
Total Current Assets	68,471	64,234	56,571	52,040	40,488	40,477
Property, Plant & Equipment	70,891	72,002	75,001	74,934	80,544	85,205
Long-Term Investments	2,397	3,061	2,076	2,198	1,768	2,468
Long-Term Deferred Tax Assets	728.4	505.05	508.51	1,920	-	-
Other Long-Term Assets	141.26	287.6	901.23	1,110	136.16	297.29
Total Assets	142,628	140,090	135,058	132,202	122,937	128,446
Accounts Payable	5,761	5,348	8,692	13,130	10,451	16,824
Accrued Expenses	966.21	1,177	1,203	633.1	608.08	820.82
Short-Term Debt	7,713	7,940	11,447	10,000	10,000	5,000
Current Portion of Long-Term Debt	-	-	-	6,337	-	-
Current Portion of Leases	25.79	28.37	26.85	23.71	2.2	-
Current Income Taxes Payable	1,314	3,293	174.79	214.38	-	-
Current Unearned Revenue	-	-	-	178.69	570	570
Other Current Liabilities	2,901	1,160	1,241	1,222	1,072	3,718
Total Current Liabilities	18,681	18,946	22,785	31,738	22,703	26,933
Long-Term Debt	-	-	5,000	-	5,928	5,440
Long-Term Leases	20.57	33.61	25.78	63.55	47.89	41.17
Other Long-Term Liabilities	538.27	1,372	252.56	461.27	225.66	225.66
Total Liabilities	19,427	20,352	28,064	32,263	29,052	33,302
Common Stock	5,317	5,317	3,544	3,544	3,544	3,544
Additional Paid-In Capital	23,290	23,290	25,068	25,068	25,068	25,068
Retained Earnings	94,600	91,138	78,382	71,327	65,273	66,532
Treasury Stock	-5.35	-5.35	-	-	-	-
Comprehensive Income & Other	0	0	0	0	0	-
Shareholders' Equity	123,201	119,738	106,994	99,939	93,885	95,144
Total Liabilities & Equity	142,628	140,090	135,058	132,202	122,937	128,446
Total Debt	7,759	8,002	16,500	16,424	15,978	10,481
Net Cash (Debt)	6,945	-243.03	-11,135	-8,543	-3,340	-9,443
Net Cash Per Share	651.96	-22.86	-1570.78	-803.46	-314.15	-888.09
Filing Date Shares Outstanding	10.63	10.63	7.09	10.63	10.63	10.63
Total Common Shares Outstanding	10.63	10.63	7.09	10.63	10.63	10.63
Working Capital	49,790	45,288	33,786	20,302	17,786	13,544
Book Value Per Share	11587.10	11261.43	15093.47	9398.78	8829.44	8947.82
Tangible Book Value	123,201	119,738	106,994	99,939	93,885	95,144
Tangible Book Value Per Share	11587.10	11261.43	15093.47	9398.78	8829.44	8947.82
Land	8,047	7,933	7,933	7,880	7,832	7,669
Buildings	58,490	57,923	53,974	52,056	52,671	52,135
Machinery	45,201	48,332	47,960	43,826	43,765	43,531
Construction In Progress	272.2	96	2,326	554	408.55	476.55

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.